By Brian Swint
Johnson & Johnson, the pharmaceutical and biotech company, has spent years trying to fend off lawsuits related to its talc products. Its latest attempt just failed again.
The stock fell 3.6% in premarket trading Tuesday to $159.95. Coming into the session, the shares had gained 15% this year.
The company faces sweeping litigation from accusations that its baby powder and other talc-based items harmed consumers. On Monday, a bankruptcy judge in Texas rejected a proposal that would have ended current and future lawsuits related to the talc products' alleged links to cancer.
It had tried to resolve the cases using a subsidiary company's bankruptcy; this was the third attempt at such a resolution. But Judge Christopher Lopez, based in Houston, said the company didn't belong in chapter 11, which is a legal status that would have protected it from further claims.
J&J said in a statement that it wouldn't appeal the decision, but would continue to fight individual claims in court.
Write to Brian Swint at brian.swint@barrons.com
This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 01, 2025 08:15 ET (12:15 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.